Back to One Day at a Time having "dodged a bullet."
I was nervous about seeing the oncologist today. But I woke up early, thinking about how long since I've don'e any real research about what's going on in the world of T-Cell Lymphoma research. I started looking and found there are some very recent clinical trials and I found a meta-analysis from November of this year, looking at several published research articles about what is going on in the world of actual treatment of AITL. It kinda felt good to use that part of my brain again. Some of the best info I found led me to look at Memorial Sloan Kettering in NY, because of some principle investigators:
Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and
Angioimmunoblastic T-Cell Lymphoma. Controversies in the Treatment of Peripheral T-cell
Lymphoma. Hemasphere. 2020 Sep
Practical Treatment Approach for Angioimmunoblastic T-Cell Lymphoma
Alison J. Moskowitz, MD1
1: Falchi L, Ma H, Klein S, Lue JK, Montanari F, Marchi E, Deng C, Kim HA, Rada
A, Jacob AT, Kinahan C, Francescone MM, Soderquist CR, Park DC, Bhagat G,
Nandakumar R, Menezes D, Scotto L, Sokol L, Shustov AR, O'Connor OA. Combined
oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a
multicenter phase 2 study. Blood. 2021 Apr 22;137(16):2161-2170. doi:
10.1182/blood.2020009004. Erratum in: Blood. 2022 Mar 10;139(10):1600. PMID:
33171487.
The last one has Dr. Shustov involved, who we went to see in Seattle a long time ago. He was a huge help.
I thought about if I need to go to one of these people who are looking at the cutting edge of what might work for AITL. There is a ton of info, most still calling prognosis "dismal." But what if they are right on the verge of a real breakthrough?
And I am still being offered CHOEP, which almost always fails long term.
I found a recent article by Dr. Haverkos, who I've gone to before from U. of Colorado.
Comments
Post a Comment